140 related articles for article (PubMed ID: 29399152)
1. CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells.
Jayaraman S; Doucet M; Kominsky SL
Oncol Lett; 2018 Jan; 15(1):871-878. PubMed ID: 29399152
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of CITED2 attenuates breast tumor growth, vessel formation and TGF-β-induced expression of VEGFA.
Jayaraman S; Doucet M; Kominsky SL
Oncotarget; 2017 Jan; 8(4):6169-6178. PubMed ID: 28008154
[TBL] [Abstract][Full Text] [Related]
3. CITED2 Modulates Breast Cancer Metastatic Ability through Effects on IKKα.
Jayaraman S; Doucet M; Lau WM; Kominsky SL
Mol Cancer Res; 2016 Aug; 14(8):730-9. PubMed ID: 27216153
[TBL] [Abstract][Full Text] [Related]
4. CITED2 modulates estrogen receptor transcriptional activity in breast cancer cells.
Lau WM; Doucet M; Huang D; Weber KL; Kominsky SL
Biochem Biophys Res Commun; 2013 Jul; 437(2):261-6. PubMed ID: 23811274
[TBL] [Abstract][Full Text] [Related]
5. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer.
Tang Z; He G; Xu J; Zhongfu L
J Surg Res; 2017 May; 211():1-7. PubMed ID: 28501104
[TBL] [Abstract][Full Text] [Related]
7. CITED2 Restrains Proinflammatory Macrophage Activation and Response.
Kim GD; Das R; Rao X; Zhong J; Deiuliis JA; Ramirez-Bergeron DL; Rajagopalan S; Mahabeleshwar GH
Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203644
[TBL] [Abstract][Full Text] [Related]
8. CITED2 limits pathogenic inflammatory gene programs in myeloid cells.
Pong Ng H; Kim GD; Ricky Chan E; Dunwoodie SL; Mahabeleshwar GH
FASEB J; 2020 Sep; 34(9):12100-12113. PubMed ID: 32697413
[TBL] [Abstract][Full Text] [Related]
9. Role of CITED2 in stem cells and cancer.
An B; Ji X; Gong Y
Oncol Lett; 2020 Oct; 20(4):107. PubMed ID: 32831926
[TBL] [Abstract][Full Text] [Related]
10. CITED2 and the modulation of the hypoxic response in cancer.
Fernandes MT; Calado SM; Mendes-Silva L; Bragança J
World J Clin Oncol; 2020 May; 11(5):260-274. PubMed ID: 32728529
[TBL] [Abstract][Full Text] [Related]
11. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
Cheung KF; Zhao J; Hao Y; Li X; Lowe AW; Cheng AS; Sung JJ; Yu J
Cancer; 2013 Mar; 119(6):1217-26. PubMed ID: 23212831
[TBL] [Abstract][Full Text] [Related]
12. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxia-inducible genes in experimental CKD and uremia.
Tanaka T; Yamaguchi J; Higashijima Y; Nangaku M
FASEB J; 2013 Oct; 27(10):4059-75. PubMed ID: 23792300
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.
Pham TH; Bak Y; Kwon T; Kwon SB; Oh JW; Park JH; Choi YK; Hong JT; Yoon DY
Cell Commun Signal; 2019 May; 17(1):53. PubMed ID: 31126309
[TBL] [Abstract][Full Text] [Related]
14. Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2.
Regel I; Merkl L; Friedrich T; Burgermeister E; Zimmermann W; Einwächter H; Herrmann K; Langer R; Röcken C; Hofheinz R; Schmid R; Ebert MP
Gastroenterology; 2012 Jul; 143(1):99-109.e10. PubMed ID: 22465428
[TBL] [Abstract][Full Text] [Related]
15. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
Liu YC; Chang PY; Chao CC
Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
[TBL] [Abstract][Full Text] [Related]
16. The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.
Jiang H; Chen C; Sun Q; Wu J; Qiu L; Gao C; Liu W; Yang J; Jun N; Dong J
Onco Targets Ther; 2016; 9():5737-5750. PubMed ID: 27729799
[TBL] [Abstract][Full Text] [Related]
17. SOX9 Knockdown-Mediated FOXO3 Downregulation Confers Neuroprotection Against Ischemic Brain Injury.
Deng Y; Ma G; Gao F; Sun X; Liu L; Mo D; Ma N; Song L; Huo X; He H; Miao Z
Front Cell Dev Biol; 2020; 8():555175. PubMed ID: 33791290
[TBL] [Abstract][Full Text] [Related]
18. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
19. Silencing of Cited2 and Akap12 genes in radiation-induced rat osteosarcomas.
Daino K; Roch-Lefevre S; Ugolin N; Altmeyer-Morel S; Guilly MN; Chevillard S
Biochem Biophys Res Commun; 2009 Dec; 390(3):654-8. PubMed ID: 19825367
[TBL] [Abstract][Full Text] [Related]
20. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
Yoon H; Lim JH; Cho CH; Huang LE; Park JW
Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
